Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis

Endoscopy. 2011:43 Suppl 2 UCTN:E326-7. doi: 10.1055/s-0030-1256741. Epub 2011 Oct 21.

Authors

C K Lee¹, J Y Park, J-J Shim, J Y Jang

Affiliation

¹ Division of Gastroenterology, Department of Internal medicine, School of Medicine, Kyung Hee University, Seoul, Korea. cklee92@paran.com

PMID: 22020709
DOI: 10.1055/s-0030-1256741

No abstract available

Publication types

Case Reports

MeSH terms

Amyloidosis / complications
Amyloidosis / diagnosis
Amyloidosis / drug therapy*
Anti-Inflammatory Agents / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Arthritis, Rheumatoid / complications
Arthritis, Rheumatoid / drug therapy
Duodenal Diseases / diagnosis
Duodenal Diseases / drug therapy
Female
Humans
Ileal Diseases / diagnosis
Ileal Diseases / drug therapy
Infliximab
Middle Aged
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal
Tumor Necrosis Factor-alpha
Infliximab